Multigrowth Factor Cream Speeds Recovery After Laser Therapy

This article originally appeared here.
Share this content:
Multigrowth Factor Cream Speeds Recovery After Laser Therapy
Multigrowth Factor Cream Speeds Recovery After Laser Therapy

WEDNESDAY, Sept. 21, 2016 (HealthDay News) -- Treatment with a multigrowth factor (MGF)-containing cream is associated with more rapid recovery after laser ablation, according to a study published online Sept. 16 in the Journal of Cosmetic Dermatology.

Sungsik Shin, M.D., from the Yonsei University College of Medicine in Seoul, South Korea, and colleagues performed a randomized controlled split-face study involving 20 patients who underwent treatment using an ablative fractional laser. Patients were randomized with respect to the side of the face treated with an MGF-containing cream or control cream. Post-treatment erythema and pigmentation were assessed, and the total area of microcrusts was evaluated. Patient satisfaction and global improvement scores were also measured.

The researchers found that the MGF-treated regions had significantly smaller areas of microcrusts. MGF cream-treated sides also had significantly higher global improvement scores for post-treatment edema and wrinkles compared with the control sides.

"The MGF cream-treated regions showed a more rapid recovery from crusts and edema," the authors write. "Thus, the use of an MGF-containing cream after laser treatment can effectively reduce recovery time."

One author is a medical director of L&C Bio, which funded the study.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »